Junxiang Luo

发表

Hypoglycemic events analysis via recurrent time-to-event (HEART) models

Haoda Fu, Yongming Qu, Junxiang Luo, 2016, Journal of biopharmaceutical statistics.

Estimation of group means in generalized linear mixed models

M. Levine, Junxiang Luo, Y. Qu, 2019, Pharmaceutical statistics.

Reduction in platelet reactivity with prasugrel 5 mg in low-body-weight patients is noninferior to prasugrel 10 mg in higher-body-weight patients: results from the FEATHER trial.

D. Foley, Junxiang Luo, S. James, 2012, Journal of the American College of Cardiology.

Prasugrel compared with high-dose clopidogrel in acute coronary syndrome

G. Montalescot, Junxiang Luo, J. Collet, 2009, Thrombosis and Haemostasis.

A comparison of prasugrel at the time of percutaneous coronary intervention or as pretreatment at the time of diagnosis in patients with non-ST-segment elevation myocardial infarction: design and rationale for the ACCOAST study.

D. Dudek, G. Montalescot, Junxiang Luo, 2011, American heart journal.

Prasugrel 5 mg in the very elderly attenuates platelet inhibition but maintains noninferiority to prasugrel 10 mg in nonelderly patients: the GENERATIONS trial, a pharmacodynamic and pharmacokinetic study in stable coronary artery disease patients.

T. Lindahl, D. Foley, Junxiang Luo, 2013, Journal of the American College of Cardiology.

Relationship Between Exposure to Prasugrel Active Metabolite and Clinical Outcomes in the TRITON‐TIMI 38 Substudy

Junxiang Luo, C. Ernest, R. Wrishko, 2012, Journal of clinical pharmacology.

The Onset of Inhibition of Platelet Aggregation With Prasugrel Compared With Clopidogrel Loading Doses Using Gatekeeping Analysis of Integrated Clinical Pharmacology Data

M. Effron, P. Kulkarni, Junxiang Luo, 2011, Journal of cardiovascular pharmacology.

A Comparison of the VerifyNow P2Y12 Point-of-Care Device and Light Transmission Aggregometry to Monitor Platelet Function with Prasugrel and Clopidogrel: An Integrated Analysis

Junxiang Luo, K. Winters, J. Jakubowski, 2010, Journal of cardiovascular pharmacology.

Lipid changes during basal insulin peglispro, insulin glargine, or NPH treatment in six IMAGINE trials

A. Chang, B. Hoogwerf, J. Bue-Valleskey, 2016, Diabetes, obesity & metabolism.

Microbial metabolites and heart failure: Friends or enemies?

Junxiang Luo, Jingjing Liu, Fuyang Mei, 2022, Frontiers in Microbiology.

Relationship of Glucose Variability With Glycated Hemoglobin and Daily Mean Glucose: A Post Hoc Analysis of Data From 5 Phase 3 Studies

A. Chang, Junxiang Luo, Y. Qu, 2018, Journal of diabetes science and technology.

Randomized Clinical Trial Comparing Basal Insulin Peglispro and Insulin Glargine in Patients With Type 2 Diabetes Previously Treated With Basal Insulin: IMAGINE 5

A. Chang, H. Rodbard, J. Bue-Valleskey, 2015, Diabetes Care.

A General Framework for Treatment Effect Estimators Considering Patient Adherence

Haoda Fu, Yongming Qu, Stephen J. Ruberg, 2020 .

Sampling over time: developing a cost effective and precise exposure assessment program.

Junxiang Luo, Rakesh Shukla, Sergey A Grinshpun, 2005, Journal of environmental monitoring : JEM.

Dose Unit Establishment for a New Basal Insulin Using Joint Modeling of Insulin Dose and Glycemic Response

A. Chang, Junxiang Luo, Y. Qu, 2018, Journal of diabetes science and technology.

A generalized weighted combination test of treatment effect for clinical trials with a sequential parallel comparison design and binary endpoint

Junxiang Luo, H. Quan, Xun Chen, 2022, Statistics in medicine.

Estimation of group means when adjusting for covariates in generalized linear models

Junxiang Luo, Y. Qu, 2015, Pharmaceutical statistics.

Piecewise Negative Binomial Regression in Analyzing Hypoglycemic Events with Missing Observations

Haoda Fu, Yongming Qu, Ming Wang, 2014 .

The effect of adjusting for baseline hypoglycemia when analyzing hypoglycemia data: a systematic analysis of 15 diabetes clinical trials.

Junxiang Luo, Y. Qu, M. Carey, 2013, Diabetes technology & therapeutics.

Analysis of hypoglycemic events using negative binomial models

Junxiang Luo, Y. Qu, 2013, Pharmaceutical statistics.

Estimating the treatment effect for adherers using multiple imputation

Yongming Qu, Junxiang Luo, Stephen J Ruberg, 2021, Pharmaceutical statistics.

Selection bias in the treatment effect for a principal stratum

Yongming Qu, Ilya Lipkovich, Stephen J. Ruberg, 2021, 2112.09541.

Implementation of tripartite estimands using adherence causal estimators under the causal inference framework

Yongming Qu, Stephen J. Ruberg, Junxiang Luo, 2020, Pharmaceutical statistics.

Evaluation and optimization of an urban PM2.5 monitoring network.

T. Reponen, S. Grinshpun, Junxiang Luo, 2005, Journal of environmental monitoring : JEM.

Utilization of treatment effect on a surrogate endpoint for planning a study to evaluate treatment effect on a final endpoint

Junxiang Luo, H. Quan, G. Paux, 2023, Pharmaceutical statistics.

Estimation of group means in generalized linear mixed models

M. Levine, Junxiang Luo, Y. Qu, 2019, Pharmaceutical statistics.

Estimating sampling frequency in pollen exposure assessment over time.

Tiina Reponen, Qi Zhang, Junxiang Luo, 2006, Journal of environmental monitoring : JEM.

T. Lindahl, D. Foley, Junxiang Luo, 2013, Journal of the American College of Cardiology.